Yes I really think that will happen. In a year's time we'll look back and say "someone could have had GNBT pre dividend for 50 cents". I think there is a lot going on that Joe is not saying yet, but it will all fall into place and NGIO will become a NAZ company soon and we'll get the dividends. Then GNBT will get on the NAZ. Then they'll announce plans that have been alluded to for NGIO such as melanoma and bladder trials, and other partnerships. Then they'll announce something on the diabetes front, either with Altucell or Oralyn or both. And of course, we'll start getting Excellogen revenues. Further down the line NGIO will be bought out, most likely for over 10 billion.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links